| Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression Y Zhu, JM Herndon, DK Sojka, KW Kim, BL Knolhoff, C Zuo, DR Cullinan, ... Immunity 47 (2), 323-338. e6, 2017 | 595 | 2017 |
| Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer S Hegde, VE Krisnawan, BH Herzog, C Zuo, MA Breden, BL Knolhoff, ... Cancer cell 37 (3), 289-307. e9, 2020 | 229 | 2020 |
| Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies RZ Panni, JM Herndon, C Zuo, S Hegde, GD Hogg, BL Knolhoff, ... Science translational medicine 11 (499), eaau9240, 2019 | 143 | 2019 |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 33 | 2022 |
| Potassium channel selectivity filter dynamics revealed by single-molecule FRET S Wang, SJ Lee, G Maksaev, X Fang, C Zuo, CG Nichols Nature chemical biology 15 (4), 377-383, 2019 | 25 | 2019 |
| Neoadjuvant FOLFIRINOX therapy is associated with increased effector T cells and reduced suppressor cells in pancreatic cancer patients H Peng, CA James, DR Cullinan, GD Hogg, JL Mudd, C Zuo, R Takchi, ... Clinical cancer research: an official journal of the American Association …, 2021 | 24 | 2021 |
| The role of fibroblast growth factor-binding protein 1 in skin carcinogenesis and inflammation MO Schmidt, KA Garman, YG Lee, C Zuo, PJ Beck, M Tan, ... Journal of Investigative Dermatology 138 (1), 179-188, 2018 | 24 | 2018 |
| Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer DC Zhou, RG Jayasinghe, JM Herndon, E Storrs, CK Mo, Y Wu, RS Fulton, ... BioRxiv, 2021.01. 13.426413, 2021 | 10 | 2021 |
| Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade VE Lander, JI Belle, NL Kingston, JM Herndon, GD Hogg, X Liu, LI Kang, ... Cancer discovery 12 (12), 2774-2799, 2022 | 6 | 2022 |
| Pancreas resident macrophage-induced fibrosis has divergent roles in pancreas inflammatory injury and PDAC JM Baer, C Zuo, LI Kang, A Alarcon de la Lastra, NC Borcherding, ... bioRxiv, 2022.02. 09.479745, 2022 | 5 | 2022 |
| Macrophage proliferation machinery leads to PDAC progression, but susceptibility to innate immunotherapy C Zuo, JM Baer, BL Knolhoff, JI Belle, X Liu, GD Hogg, C Fu, NL Kingston, ... bioRxiv, 2021.11. 08.467770, 2021 | 3 | 2021 |
| Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy C Zuo, JM Baer, BL Knolhoff, JI Belle, X Liu, A Alarcon De La Lastra, C Fu, ... Journal of Experimental Medicine 220 (6), e20212062, 2023 | 2 | 2023 |
| A role for glutamine 183 in the folate oxidative half-reaction of methylenetetrahydrofolate reductase from Escherichia coli C Zuo, AL Jolly, AP Nikolova, DI Satzer, S Cao, JS Sanchez, DP Ballou, ... Archives of biochemistry and biophysics 642, 63-74, 2018 | 2 | 2018 |
| Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer H Peng, L Li, C Zuo, MY Chen, X Zhang, NB Myers, GD Hogg, ... Frontiers in immunology 13, 1039226, 2022 | 1 | 2022 |
| Pancreatic Cancer S Hegde, VE Krisnawan, BH Herzog, C Zuo, MA Breden, BL Knolhoff immunity 580, 257-62, 2020 | 1 | 2020 |
| CD11b agonists reprogram innate immunity to sensitize pancreatic cancer to immunotherapies RZ Panni, JM Herndon, C Zuo, S Hegde, GD Hogg, BL Knolhoff, ... Science translational medicine 11 (499), 2019 | 1 | 2019 |
| Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer CA James, JM Baer, C Zou, UY Panni, BL Knolhoff, GD Hogg, ... Cancer Immunology Research, OF1-OF13, 2023 | | 2023 |
| Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity X Liu, GD Hogg, C Zuo, NC Borcherding, JM Baer, VE Lander, LI Kang, ... Cancer Cell, 2023 | | 2023 |
| Context-dependent induction of interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients X Liu, G Hogg, C Zuo, J Baer, V Lander, L Kang, N Borcherding, ... Cancer Research 83 (7_Supplement), 5964-5964, 2023 | | 2023 |
| Context-dependent triggering of STING-interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients X Liu, GD Hogg, C Zuo, JM Baer, VE Lander, L Kang, NC Borcherding, ... bioRxiv, 2022.03. 22.485233, 2022 | | 2022 |
